CN107091925B - Kit for detecting periodontitis related protein - Google Patents

Kit for detecting periodontitis related protein Download PDF

Info

Publication number
CN107091925B
CN107091925B CN201710489328.8A CN201710489328A CN107091925B CN 107091925 B CN107091925 B CN 107091925B CN 201710489328 A CN201710489328 A CN 201710489328A CN 107091925 B CN107091925 B CN 107091925B
Authority
CN
China
Prior art keywords
periodontitis
kit
hydrophilic reagent
periodontal disease
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201710489328.8A
Other languages
Chinese (zh)
Other versions
CN107091925A (en
Inventor
孟玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Yuan Kangrui Biological Technology Co.,Ltd.
Original Assignee
Zhejiang Yuan Kangrui Biological Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Yuan Kangrui Biological Technology Co ltd filed Critical Zhejiang Yuan Kangrui Biological Technology Co ltd
Priority to CN201710489328.8A priority Critical patent/CN107091925B/en
Publication of CN107091925A publication Critical patent/CN107091925A/en
Application granted granted Critical
Publication of CN107091925B publication Critical patent/CN107091925B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms

Abstract

The invention specifically discloses an antibody chip and a kit for detecting periodontitis related protein, comprising an antibody chip, a periodontal disease related protein standard mixture and a biotin-labeled periodontal disease related protein detection antibody mixture; and fluorescein Cy 3-labeled streptavidin; the antibody chip takes a slide glass treated by a hydrophilic reagent containing alkyl glycoside as a solid phase carrier, and a specific antibody mixture of a plurality of periodontal disease-related proteins is spotted on the solid phase carrier under the conditions of 4-20 ℃ and 20-29% of humidity. The antibody chip kit overcomes the defects of complex operation, single detection index, low sensitivity and the like in the prior art, and has the advantages of low price, convenience, sensitivity, accuracy, high flux, small sample consumption, popularization in common laboratories, large scale and the like.

Description

Kit for detecting periodontitis related protein
Technical Field
The invention relates to the technical field of biological detection, in particular to a kit for detecting periodontitis related protein.
Background
Periodontitis is a chronic inflammation of the periodontal supporting tissue caused primarily by local factors. The age of onset is more common after age 35 years. If gingivitis is not treated timely, inflammation can diffuse from the gingiva to the deep layer to the periodontal ligament, alveolar bone and cementum, and periodontitis can develop. Because early stage has no obvious subjective symptoms and is easy to ignore, the symptoms are serious and even the teeth can not be kept. Therefore, the propaganda and education must be strengthened to make the patient see a doctor early and treat the disease in time. The early symptoms of periodontitis are not obvious, and patients often have the manifestations of secondary gingival bleeding or halitosis, similar to the symptoms of gingivitis. During examination, swelling, soft and dark red of gingival margin, gingival papilla and attached gingiva can be seen, and bleeding is easy to occur during probing.
Gingival Crevicular Fluid (GCF) refers to the fluid that permeates from the gingival connective tissue into the gingival sulcus through the epithelium and associated epithelium in the sulcus. Healthy patients have very little gingival crevicular fluid, and the outflow of gingival crevicular fluid is proportional to the degree of inflammation at the site. The gingival crevicular fluid is primarily derived from serum, while the other components are derived from serum, adjacent periodontal tissue and bacteria, respectively. The gingival crevicular fluid comprises various electrolytes, proteins, glucose, enzymes and the like, also contains various biological macromolecules such as leucocytes, exfoliated epithelial cells and the like, the biological macromolecules can be used as markers for detecting periodontitis, and the proteins of the gingival crevicular fluid can be used as ideal pathological markers for detecting periodontitis.
The existing detection method for periodontitis can only judge the disease condition from pathological forms by comprising observation and X-ray detection, and the judgment of the disease condition is accompanied by the subjective factors of doctors, so the detection result is not objective. Therefore, there is an urgent need to develop a method for rapidly detecting periodontitis using biomarkers.
Disclosure of Invention
In view of the above-mentioned shortcomings of the prior art, the present invention provides a kit for detecting periodontitis-related protein, so as to solve the above-mentioned technical problems.
A kit for detecting periodontitis related protein comprises an antibody chip, a periodontal disease related protein standard mixture and a biotin-labeled periodontal disease related protein detection antibody mixture; and fluorescein Cy 3-labeled streptavidin; the antibody chip takes a slide glass treated by a hydrophilic reagent containing alkyl glycoside as a solid phase carrier, and a specific antibody mixture of a plurality of periodontal disease-related proteins is spotted on the solid phase carrier under the conditions of 4-20 ℃ and 20-29% of humidity.
Drawings
Fig. 1 is a schematic structural view of the present invention.
Detailed Description
The invention is further described with reference to the following examples.
A kit for detecting periodontitis related protein, as shown in figure 1, comprises an antibody chip, a periodontal disease related protein standard mixture, a biotin-labeled periodontal disease related protein detection antibody mixture; and fluorescein Cy 3-labeled streptavidin; the antibody chip takes a slide glass treated by a hydrophilic reagent containing alkyl glycoside as a solid phase carrier, and a specific antibody mixture of a plurality of periodontal disease-related proteins is spotted on the solid phase carrier under the conditions of 4-20 ℃ and 20-29% of humidity.
Preferably, the periodontitis-associated protein detection antibody cocktail is a cocktail of antibodies specific for fibronectin receptor (FN), laminin receptor (LN), lymphocyte function-related molecule-1 (LFA-1), clear connexin receptor (LRP), endothelial leukocyte adhesion molecule-1 (ELAM-1), platelet α -granulin (GMP-140), mucosal vascular adhesion (HCAM), and peripheral lymph node vascular adhesion (LAM-1).
The kit for detecting periodontitis-associated protein according to the present invention is suitable for the combination of antibodies specific to 8 periodontitis-associated proteins, fibronectin receptor (FN), laminin receptor (LN), lymphocyte function-associated molecule-1 (LFA-1), vitronectin receptor (LRP), endothelial leukocyte adhesion molecule-1 (ELAM-1), platelet α -granulin (GMP-140), mucosal vascular adhesion (HCAM) and peripheral lymph node vascular adhesion (LAM-1).
Preferably, the hydrophilic reagent is a deionized water solution containing 0.03-0.5% of alkyl glycoside, 0.2-0.8% of glycerol and 0.06-0.1% of polyethylene glycol 6000 by mass percent; the method for treating the glass slide by using the hydrophilic reagent comprises the steps of soaking the glass slide in the hydrophilic reagent for 6-15 minutes, and freeze-drying at 4 ℃. Preferably, the periodontitis-related protein detection antibody mixture is spotted on a solid phase carrier under the conditions of 4-8 ℃ and 20-25% of humidity.
Preferably, the periodontitis-associated protein detection antibody mixture is spotted on the solid phase carrier at 4 ℃ and 22% humidity.
Preferably, the hydrophilic reagent is a deionized water solution containing 0.3% of alkyl glycoside, 0.2% of glycerol and 0.08% of polyethylene glycol 6000 by mass; the method for treating the glass slide by using the hydrophilic reagent comprises the steps of soaking the glass slide in the hydrophilic reagent for 10 minutes, and freeze-drying at 4 ℃.
According to the invention, through comparing various methods for processing the glass slide, the method discovers that the background of the glass slide processed by the hydrophilic reagent containing the alkyl glycoside is low, the detection sensitivity is high, more than ten periodontal disease related proteins can be detected at one time, and the sensitivity of the detected periodontal disease related proteins can reach the ELISA detection sensitivity of a single protein. The antibody chip kit overcomes the defects of complex operation, single detection index, low sensitivity and the like in the prior art, and has the advantages of low price, convenience, sensitivity, accuracy, high flux, small sample consumption, popularization in common laboratories, large scale and the like.
The sensitivity of antibodies specific to different periodontal disease-related proteins in the on-chip detection system of the present invention is different, and therefore, if some antibodies against periodontal disease-related proteins with low sensitivity are combined with some antibodies against periodontal disease-related proteins with high sensitivity, omission of periodontal disease-related proteins with low sensitivity is caused.
Experimental examples antibody chip vector screening
Screening of antibody chip carriers: the conventional antibody chip mostly uses a nitrocellulose membrane as a carrier, and the nitrocellulose membrane is of a multilayer structure, so that the washing difficulty of the chip is high, the background of the chip is high, and the result fluctuation is large. Meanwhile, the nitrocellulose membrane is fragile and not easy to operate on a large scale, and is not generally used for large-scale clinical samples. The traditional slide is cheap and has low background, which brings breakthrough to the wide application of the diagnosis and research fields. We screened slides that were not treated by the active method on the market, and the effect of the slide spotting was unstable, both for the aldehyde and the amino groups. The temperature and the active reagent components on the surface of the slide are obtained through a large amount of screening, and the key for determining the sample application effect of the slide is.
A suitable carrier for an antibody chip was explored using the following protocol for slide treatment in 3:
the group A is an amination slide, and the purchased commercial slide is not processed;
group B is polylysine slide: adding polylysine diluted by PBS into a common glass slide, soaking for 0.5-1 hour, and then cleaning with pure water to prepare a polylysine glass slide;
group C is slides treated with hydrophilic reagents: soaking a common glass slide in a hydrophilic reagent for 3-5 minutes, and airing at room temperature; the hydrophilic reagent is a deionized water solution containing 0.03-0.5% of alkyl glycoside, 0.2-0.8% of glycerol and 0.06-0.1% of polyethylene glycol 6000 in percentage by mass; the method for treating the glass slide by using the hydrophilic reagent comprises the steps of soaking the glass slide in the hydrophilic reagent for 6-15 minutes, and freeze-drying at 4 ℃.
The spotting effect of various slides is different, 3 groups of slides are combined with the antibody, then the secondary antibody and the substrate are added, and the sensitivity screening results under different temperature and humidity conditions are shown in the following table 1, wherein the index of the sensitivity shown in the table 1 is the lowest detection line with the unit ng/ml.
TABLE 1
Figure GDA0002287015120000041
As can be seen from the data in Table 1, the sensitivity of the treatment methods in group C was higher than that of group A and group B in 3 different treatment humidities at 4 ℃, 8 ℃ and 16 ℃, and it was found that the treatment methods in group C were very suitable for the preparation of the antibody chip of the present invention.
Finally, it should be noted that the above embodiments are only used for illustrating the technical solutions of the present invention, and not for limiting the protection scope of the present invention, although the present invention is described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications or equivalent substitutions can be made on the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention.

Claims (4)

1. A kit for detecting periodontitis related protein is characterized by comprising an antibody chip, a periodontal disease related protein standard mixture and a biotin-labeled periodontal disease related protein detection antibody mixture; and fluorescein Cy 3-labeled streptavidin; the antibody chip takes a slide glass treated by a hydrophilic reagent containing alkyl glycoside as a solid phase carrier, and a specific antibody mixture of various periodontal disease related proteins is spotted on the solid phase carrier under the conditions of 4-20 ℃ and 20-29% of humidity;
the hydrophilic reagent is a deionized water solution containing 0.03-0.5% of alkyl glycoside, 0.2-0.8% of glycerol and 0.06-0.1% of polyethylene glycol 6000 in percentage by mass; the method for treating the glass slide by using the hydrophilic reagent comprises the steps of soaking the glass slide in the hydrophilic reagent for 6-15 minutes, and freeze-drying at 4 ℃;
the periodontitis-associated protein detection antibody mixture is a mixture of specific antibodies of fibronectin receptor (FN), laminin receptor (LN), lymphocyte function-related molecule-1 (LFA-1), clear connexin receptor (LRP), endothelial leukocyte adhesion molecule-1 (ELAM-1), platelet α -granula membrane protein (GMP-140), mucosal vascular adhesion (HCAM) and peripheral lymph node vascular adhesion (LAM-1).
2. The kit for detecting a periodontitis-associated protein according to claim 1, wherein the periodontitis-associated protein detection antibody mixture is spotted on the solid phase carrier at 4 to 8 ℃ and 20 to 25% humidity.
3. The kit for detecting a periodontitis-associated protein according to claim 1, wherein the periodontitis-associated protein detection antibody mixture is spotted on the solid phase carrier at 4 ℃ under a humidity of 22%.
4. The kit for detecting periodontitis-associated protein according to claim 1, wherein the hydrophilic reagent is a deionized water solution of 0.3% of alkyl glycoside, 0.2% of glycerol, and 0.08% of polyethylene glycol 6000 by mass; the method for treating the glass slide by using the hydrophilic reagent comprises the steps of soaking the glass slide in the hydrophilic reagent for 10 minutes, and freeze-drying at 4 ℃.
CN201710489328.8A 2017-06-24 2017-06-24 Kit for detecting periodontitis related protein Active CN107091925B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710489328.8A CN107091925B (en) 2017-06-24 2017-06-24 Kit for detecting periodontitis related protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710489328.8A CN107091925B (en) 2017-06-24 2017-06-24 Kit for detecting periodontitis related protein

Publications (2)

Publication Number Publication Date
CN107091925A CN107091925A (en) 2017-08-25
CN107091925B true CN107091925B (en) 2020-06-23

Family

ID=59640879

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710489328.8A Active CN107091925B (en) 2017-06-24 2017-06-24 Kit for detecting periodontitis related protein

Country Status (1)

Country Link
CN (1) CN107091925B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110967336A (en) * 2018-09-28 2020-04-07 陈洁 Periodontal disease detection kit and use method thereof
CN109459568A (en) * 2019-01-15 2019-03-12 西安交通大学 Paper base periodontitis detection device and periodontitis detection method
CN113373210A (en) * 2021-03-11 2021-09-10 广州医科大学附属口腔医院(广州医科大学羊城医院) Application of Act1 in macrophages as periodontitis disease marker

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006234831A (en) * 2006-04-18 2006-09-07 Toyobo Co Ltd Reagent for immunoassay
EP2902786B1 (en) * 2008-06-30 2018-12-19 Sekisui Medical Co., Ltd. Porous solid phase for binding assay, and binding assay method using the same
CA2827894A1 (en) * 2011-02-22 2012-08-30 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Circulating biomarkers
CN103869068B (en) * 2012-12-18 2016-03-09 广州瑞博奥生物科技有限公司 A kind of antibody chip kit for kinds of tumors diagnosis
WO2014186874A1 (en) * 2013-05-23 2014-11-27 Yyz Pharmatech, Inc. Methods and compositions for enzyme linked immuno and hybridization mass spectrometric assay
CN104655851B (en) * 2013-11-22 2018-08-17 广州瑞博奥生物科技有限公司 A kind of simultaneous quantitative detects the antibody chip kit of multiple receptors

Also Published As

Publication number Publication date
CN107091925A (en) 2017-08-25

Similar Documents

Publication Publication Date Title
CN107091925B (en) Kit for detecting periodontitis related protein
CN103336126B (en) A kind of agglutinin test chip for saliva sample and disposal route thereof
CN104977284B (en) A kind of capture of fetal nucleated red blood and identification method
KR101222437B1 (en) Biomarker
CA2845317A1 (en) Saliva collection, processing, stabilization, and storage method
CN1173182C (en) Albumen chip for detecting autoimmunity antibody of diabetes, as well as preparation and detection method
CN1766634A (en) Method for detecting mammaglobin and kit therefor
CN101042399A (en) Diabetes autoantibody immunoblotting reagent kit
WO2023104059A1 (en) Circulating tumor cell detection material, detector and detection method
US20120264142A1 (en) Detection of b-cell activating factor as a biomarker for antibody mediated rejection in transplant recipients
CN105755136B (en) A kind of No. 12 chromosome centromere probe reagent boxes of people and its preparation method and application
CN100385014C (en) Gene mutation related with LVA (large vesti-bular aqueduct) and its detection method
WO2013054984A1 (en) Composition for diagnosis of lung cancer and diagnosis kit of lung cancer
CN113917160A (en) Specificity method for detecting breast cancer circulating tumor cells by using HER2 antibody immunofluorescence method
CN103267851A (en) Kit for detecting premature rupture of membrane, and preparation method thereof
CN106636388A (en) Gene for huntington disease diagnosis and application of gene, protein coded by gene and application of protein
CN106596936A (en) Method for in-vitro quantitative determination of vWF-CP enzyme activity, detection kit and preparation method of detection kit
CN100368561C (en) Vestibule water catheter enlarging related gene mutation and detecting method thereof
CN1266476C (en) Reagent box, for diagnosing Down's syndrome in early gestational period by pregnancy correlative protein-A
CN115436638A (en) Application of PA28gamma detection reagent in preparation of oral submucosa fibrosis determination and malignant proliferation prediction kit
CN100350056C (en) Chlamys Farreri pathogeny rickettsia in situ hybridization detection method and its reagent kit
CN101245382B (en) Reagent kit for detecting 611G>T mutation of large vestibular aqueduct related gene SLC26A4
CN110261620B (en) Cell immunofluorescence kit for determining human serum phosphotyrosine adaptor protein ShcA antibody and preparation method and application thereof
CN101230396B (en) Reagent case for detecting 589G >A mutation of large vestibular aqueduct related gene SLC26A4
CN101245383B (en) Reagent kit for detecting 812A>G mutation of large vestibular aqueduct related gene SLC26A4

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20200514

Address after: 314113 Room 101, D8 Building, 555 Pioneer Road, Dayun Town, Jiashan County, Jiaxing City, Zhejiang Province

Applicant after: Zhejiang Yuan Kangrui Biological Technology Co.,Ltd.

Address before: Three, five floor, Fourth Industrial Zone, Nanshan Avenue, Nanshan street, Shenzhen, Guangdong, Nanshan District 518000, China

Applicant before: SHENZHEN YUANGUANG'AN INTELLIGENT TECHNOLOGY Co.,Ltd.

GR01 Patent grant
GR01 Patent grant